正海生物：2025年半年度净利润约4649万元，同比下降45.97%

Core Viewpoint - Zhenghai Biological reported a decline in both revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [2] Financial Performance - The company's operating revenue for the first half of 2025 was approximately 188 million yuan, a year-on-year decrease of 5.14% [2] - The net profit attributable to shareholders was around 46.49 million yuan, reflecting a significant year-on-year decline of 45.97% [2] - Basic earnings per share were reported at 0.26 yuan, down 45.83% compared to the previous year [2]